Nathan Hand, PA
Physician Assistant · Dover
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 21 years
- Graduated 2005
Offices
1 location · Campbell Dermatology PA · 19 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Nathan Hand’s office at (603) 742-5556 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$87,176
Medicare paid this office $87,176 for 642 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 403 | $28,238 | $53 |
| Destruction of precancer skin growth, 1 growth | 259 | $10,956 | $35 |
| Destruction of skin growth, 1-14 growths | 114 | $9,434 | $70 |
| Biopsy of related skin growth, first growth | 132 | $8,705 | $60 |
| New patient visit (30+ min) | 128 | $8,024 | $63 |
See all 14 services
| Short return visit (20+ min) | 403 | $28,238 | $53 |
| Destruction of precancer skin growth, 1 growth | 259 | $10,956 | $35 |
| Destruction of skin growth, 1-14 growths | 114 | $9,434 | $70 |
| Biopsy of related skin growth, first growth | 132 | $8,705 | $60 |
| New patient visit (30+ min) | 128 | $8,024 | $63 |
| Destruction of precancer skin growth, 2-14 growths | 194 | $3,526 | $4 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 15 | $2,666 | $178 |
| Return visit (30+ min) | 29 | $2,434 | $72 |
| Short return visit | 47 | $1,793 | $34 |
| Destruction of precancer skin growth, 15 or more growths | 11 | $1,228 | $94 |
| Biopsy of related skin growth, each additional growth | 24 | $1,059 | $34 |
| New patient visit (15+ min) | 24 | $862 | $36 |
| Injection into skin growth, 1-7 growths | 16 | $781 | $31 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 18 | $26 | None |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 12 | More than 66% of doctors who do this |
| Removal of nail tissue | 1-10 | None |
| Removal of skin lesions | 872 | More than 92% of doctors who do this |
| Removal of tissue | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 196 | More than 85% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 496 | 285 | 490 | 764 | 546 | 893 |
| Destruction of precancer skin growth, 1 growth | 174 | 124 | 191 | 261 | 191 | 313 |
| Biopsy of related skin growth, first growth | 41 | 23 | 92 | 144 | 89 | 146 |
| Destruction of skin growth, 1-14 growths | 85 | 53 | 55 | 61 | 58 | 134 |
| Biopsy of related skin growth, each additional growth | – | – | 25 | 33 | 13 | 31 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | – | – | – | 27 | – | 15 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
642 Original Medicare patients in 2024. Average age 73 · Under 65 6% · 85 and older 10% · Women 43% · Also on Medicaid 7% · Health risk score 1.06. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 71% · Diabetes 23% · Coronary heart disease 22% · Depression 22% · Chronic kidney disease 16% · Cancer 16% · Atrial fibrillation 16% · COPD 15% · Heart failure 14% · Stroke 7% · Dementia 5%.
The office billed $385,204, Medicare allowed $123,746 and paid $87,176; for 2,529 services of 44 kinds; $647 of it was for drugs given in the office and $86,528 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 642 | 2,529 | 73 | 1.06 | $385,204 | $87,176 |
| 2023 | 469 | 1,512 | 74 | 1.02 | $232,985 | $51,513 |
| 2022 | 471 | 1,943 | 75 | 1.01 | $317,993 | $66,994 |
| 2021 | 403 | 1,324 | 75 | 0.96 | $203,951 | $47,421 |
| 2020 | 274 | 903 | 73 | 0.98 | $139,400 | $30,088 |
| 2019 | 367 | 1,495 | 72 | 1.06 | $212,637 | $47,845 |
| 2018 | 330 | 1,300 | 71 | 1.06 | $155,485 | $37,513 |
| 2017 | 327 | 1,345 | 70 | 1.05 | $130,853 | $42,077 |
| 2016 | 302 | 1,107 | 70 | 0.94 | $69,678 | $35,535 |
| 2015 | 273 | 964 | 69 | 0.99 | $69,833 | $32,732 |
| 2014 | 252 | 963 | 69 | 0.84 | $71,824 | $33,383 |
| 2013 | 212 | 773 | 68 | 0.90 | $71,675 | $27,405 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Short return visit (20+ min) | 257 | $16,096 | $52 |
| New patient visit (30+ min) | 120 | $7,214 | $60 |
| Destruction of precancer skin growth, 1 growth | 166 | $6,455 | $34 |
| Biopsy of related skin growth, first growth | 84 | $5,335 | $60 |
| Destruction of skin growth, 1-14 growths | 55 | $4,169 | $72 |
| Destruction of precancer skin growth, 2-14 growths | 123 | $2,302 | $4 |
| Short return visit | 53 | $2,025 | $35 |
| New patient visit (15+ min) | 35 | $1,436 | $41 |
| Return visit (30+ min) | 17 | $1,164 | $58 |
| Biopsy of related skin growth, each additional growth | 12 | $459 | $35 |
2022: 12 services
| Short return visit (20+ min) | 267 | $16,991 | $51 |
| Biopsy of related skin growth, first growth | 132 | $8,396 | $58 |
| Destruction of precancer skin growth, 1 growth | 207 | $8,388 | $32 |
| New patient visit (30+ min) | 99 | $6,203 | $63 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 26 | $5,464 | $202 |
| Destruction of skin growth, 1-14 growths | 49 | $4,092 | $67 |
| Destruction of precancer skin growth, 2-14 growths | 157 | $3,182 | $4 |
| Short return visit | 60 | $2,252 | $30 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 22 | $2,071 | $86 |
| Destruction of precancer skin growth, 15 or more growths | 13 | $1,274 | $98 |
| New patient visit (15+ min) | 33 | $1,221 | $37 |
| Biopsy of related skin growth, each additional growth | 24 | $1,052 | $32 |
2021: 10 services
| Short return visit (20+ min) | 202 | $11,749 | $52 |
| Destruction of precancer skin growth, 1 growth | 173 | $6,903 | $36 |
| Biopsy of related skin growth, first growth | 85 | $6,421 | $70 |
| New patient visit (30+ min) | 67 | $4,685 | $70 |
| Destruction of skin growth, 1-14 growths | 48 | $3,871 | $70 |
| Destruction of precancer skin growth, 2-14 growths | 119 | $2,150 | $4 |
| New patient visit (15+ min) | 35 | $1,738 | $50 |
| Short return visit | 51 | $1,717 | $32 |
| Biopsy of related skin growth, each additional growth | 16 | $938 | $38 |
| Return visit (30+ min) | 12 | $728 | $61 |
2020: 7 services
| Return visit (30+ min) | 102 | $7,264 | $66 |
| Short return visit (20+ min) | 133 | $6,268 | $44 |
| Destruction of precancer skin growth, 1 growth | 111 | $4,711 | $38 |
| Destruction of skin growth, 1-14 growths | 48 | $3,951 | $75 |
| Biopsy of related skin growth, first growth | 23 | $1,389 | $60 |
| Destruction of precancer skin growth, 2-14 growths | 75 | $1,259 | $4 |
| New patient visit (15+ min) | 12 | $468 | $39 |
2019: 10 services
| Short return visit (20+ min) | 220 | $12,637 | $46 |
| Return visit (30+ min) | 99 | $7,593 | $69 |
| Destruction of precancer skin growth, 1 growth | 138 | $6,811 | $39 |
| Destruction of skin growth, 1-14 growths | 73 | $6,532 | $77 |
| Biopsy of related skin growth, first growth | 40 | $2,635 | $64 |
| Destruction of precancer skin growth, 2-14 growths | 98 | $2,100 | $4 |
| New patient visit (15+ min) | 20 | $919 | $46 |
| New patient visit (10+ min) | 16 | $486 | $30 |
| Short return visit | 13 | $397 | $28 |
| Insertion of needle into vein for collection of blood sample | 13 | $91 | $3 |
2018: 8 services
| Short return visit (20+ min) | 224 | $11,288 | $42 |
| Destruction of precancer skin growth, 1 growth | 109 | $4,991 | $38 |
| Destruction of skin growth, 1-14 growths | 59 | $4,970 | $74 |
| Return visit (30+ min) | 49 | $3,811 | $73 |
| Biopsy of single growth of skin and/or tissue | 26 | $1,519 | $58 |
| Destruction of precancer skin growth, 2-14 growths | 84 | $1,359 | $4 |
| New patient visit (15+ min) | 21 | $1,017 | $48 |
| Short return visit | 20 | $632 | $30 |
2017: 8 services
| Short return visit (20+ min) | 226 | $13,233 | $45 |
| Destruction of precancer skin growth, 1 growth | 123 | $5,752 | $39 |
| Destruction of skin growth, 1-14 growths | 66 | $5,023 | $68 |
| Biopsy of single growth of skin and/or tissue | 39 | $2,994 | $71 |
| Return visit (30+ min) | 49 | $2,953 | $55 |
| Destruction of precancer skin growth, 2-14 growths | 90 | $1,712 | $4 |
| New patient visit (15+ min) | 16 | $718 | $45 |
| Short return visit | 14 | $390 | $28 |
2016: 8 services
| Short return visit (20+ min) | 193 | $10,239 | $42 |
| Destruction of precancer skin growth, 1 growth | 114 | $5,271 | $41 |
| Destruction of skin growth, 1-14 growths | 56 | $5,004 | $70 |
| Return visit (30+ min) | 59 | $4,166 | $65 |
| Biopsy of single growth of skin and/or tissue | 30 | $2,150 | $69 |
| Destruction of precancer skin growth, 2-14 growths | 84 | $1,197 | $4 |
| New patient visit (15+ min) | 21 | $940 | $45 |
| Short return visit | 14 | $385 | $26 |
2015: 9 services
| Return visit (30+ min) | 92 | $6,181 | $62 |
| Short return visit (20+ min) | 109 | $5,209 | $45 |
| Destruction of precancer skin growth, 1 growth | 99 | $4,681 | $40 |
| Destruction of skin growth, 1-14 growths | 55 | $4,492 | $74 |
| Biopsy of single growth of skin and/or tissue | 30 | $2,134 | $71 |
| Short return visit | 50 | $1,224 | $21 |
| Destruction of precancer skin growth, 2-14 growths | 62 | $1,113 | $4 |
| Bacterial culture, any other source except urine, blood or stool, aerobic | 11 | $126 | $11 |
| Insertion of needle into vein for collection of blood sample | 12 | $44 | $3 |
2014: 11 services
| Return visit (30+ min) | 117 | $9,082 | $69 |
| Destruction of precancer skin growth, 1 growth | 83 | $4,689 | $45 |
| Destruction of skin growth, 1-14 growths | 45 | $3,644 | $73 |
| Short return visit (20+ min) | 56 | $2,517 | $41 |
| Biopsy of single growth of skin and/or tissue | 30 | $2,134 | $63 |
| Destruction of precancer skin growth, 2-14 growths | 60 | $2,103 | $7 |
| Short return visit | 53 | $1,557 | $26 |
| New patient visit (30+ min) | 15 | $991 | $66 |
| New patient visit (15+ min) | 15 | $723 | $48 |
| New patient visit (10+ min) | 14 | $216 | $15 |
| Insertion of needle into vein for collection of blood sample | 16 | $62 | $3 |
2013: 10 services
| Return visit (30+ min) | 95 | $7,233 | $64 |
| Destruction of precancer skin growth, 1 growth | 77 | $5,175 | $51 |
| Short return visit (20+ min) | 55 | $2,705 | $41 |
| Destruction of skin growth, 1-14 growths | 23 | $2,002 | $77 |
| Short return visit | 57 | $1,764 | $28 |
| Biopsy of single growth of skin and/or tissue | 23 | $1,522 | $63 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 11 | $1,380 | $125 |
| Destruction of precancer skin growth, 2-14 growths | 55 | $1,213 | $5 |
| New patient visit (15+ min) | 13 | $474 | $36 |
| Biopsy of each additional growth of skin and/or tissue | 12 | $306 | $20 |
Medicaid work
$8,219 in 2024
Medicaid paid $8,219 for 222 billed services this clinician did in 2024, up to 24 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 145 | $5,260 |
| New patient visit (30+ min) | 65 | $2,407 |
| Return visit (30+ min) | 12 | $552 |
| 2024 | 222 | 3 | 24 | $8,219 |
| 2022 | 94 | 2 | 27 | $2,163 |
See the largest Medicaid services in earlier years
2022
| Short return visit (20+ min) | 50 | $1,407 |
| New patient visit (30+ min) | 44 | $756 |
Drugs they prescribed that Part D paid
$179,926
Pharmacies billed $179,926 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 664) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
633 generic and 31 brand-name prescriptions · $179,926 in drug cost · 53 antibiotic prescriptions to 34 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Clobetasol Propionate | 87 | $3,405 | $39 |
| Fluorouracil | 47 | $3,323 | $71 |
| Metronidazole | 28 | $1,466 | $52 |
| Econazole Nitrate | 26 | $1,293 | $50 |
| Ketoconazole | 63 | $898 | $14 |
See all 14 drugs
| Clobetasol Propionate | 87 | $3,405 | $39 |
| Fluorouracil | 47 | $3,323 | $71 |
| Metronidazole | 28 | $1,466 | $52 |
| Econazole Nitrate | 26 | $1,293 | $50 |
| Ketoconazole | 63 | $898 | $14 |
| Triamcinolone Acetonide | 59 | $501 | $8 |
| Clindamycin Phosphate | 16 | $429 | $27 |
| Doxycycline Hyclate | 16 | $400 | $25 |
| Hydrocortisone | 48 | $363 | $8 |
| Fluocinonide | 11 | $278 | $25 |
| Cephalexin | 26 | $270 | $10 |
| Mupirocin | 42 | $246 | $6 |
| Methotrexate | 13 | $86 | $7 |
| Prednisone | 17 | $45 | $3 |
Year by year
| 2024 | 664 | 316 | 0% (0) | 5% | $179,926 |
| 2023 | 627 | 277 | None | 4% | $134,228 |
| 2022 | 439 | 209 | None | 3% | $68,193 |
| 2021 | 487 | 202 | 0% (0) | 10% | $58,848 |
| 2020 | 534 | 203 | 0% (0) | 13% | $95,123 |
| 2019 | 740 | 263 | 0% (0) | 18% | $122,120 |
| 2018 | 551 | 220 | 0% (0) | 16% | $118,815 |
| 2017 | 488 | 190 | None | 16% | $88,395 |
| 2016 | 488 | 207 | None | 14% | $91,569 |
| 2015 | 338 | 147 | None | 15% | $45,158 |
| 2014 | 305 | 145 | 0% (0) | None | $36,557 |
| 2013 | 280 | 124 | 0% (0) | None | $26,757 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Clobetasol Propionate | 88 | $7,805 | $89 |
| Fluorouracil | 42 | $3,425 | $82 |
| Econazole Nitrate | 37 | $2,320 | $63 |
| Ketoconazole | 61 | $1,417 | $23 |
| Triamcinolone Acetonide | 82 | $990 | $12 |
| Hydrocortisone | 44 | $892 | $20 |
| Metronidazole | 11 | $870 | $79 |
| Clindamycin Phosphate | 17 | $582 | $34 |
| Doxycycline Monohydrate | 15 | $457 | $30 |
| Doxycycline Hyclate | 17 | $302 | $18 |
| Mupirocin | 30 | $290 | $10 |
| Methotrexate | 17 | $220 | $13 |
| Minoxidil | 11 | $203 | $18 |
| Folic Acid | 11 | $25 | $2 |
2022: 11 drugs
| Calcipotriene | 12 | $3,590 | $299 |
| Clobetasol Propionate | 40 | $2,766 | $69 |
| Fluorouracil | 26 | $2,369 | $91 |
| Metronidazole | 12 | $865 | $72 |
| Doxycycline Monohydrate | 22 | $854 | $39 |
| Triamcinolone Acetonide | 80 | $827 | $10 |
| Ketoconazole | 21 | $673 | $32 |
| Ciclopirox | 17 | $595 | $35 |
| Hydrocortisone | 21 | $334 | $16 |
| Mupirocin | 33 | $328 | $10 |
| Cephalexin | 14 | $169 | $12 |
2021: 16 drugs
| Calcipotriene | 13 | $2,570 | $198 |
| Metronidazole | 24 | $1,787 | $74 |
| Fluorouracil | 15 | $1,777 | $118 |
| Tretinoin | 17 | $1,566 | $92 |
| Fluocinonide | 18 | $1,522 | $85 |
| Clobetasol Propionate | 28 | $1,511 | $54 |
| Clindamycin Phosphate | 25 | $886 | $35 |
| Betamethasone Diprop Augmented | 26 | $866 | $33 |
| Ketoconazole | 33 | $852 | $26 |
| Doxycycline Monohydrate | 15 | $625 | $42 |
| Desonide | 14 | $569 | $41 |
| Triamcinolone Acetonide | 58 | $529 | $9 |
| Econazole Nitrate | 11 | $365 | $33 |
| Ciclopirox | 14 | $353 | $25 |
| Spironolactone | 22 | $345 | $16 |
| Mupirocin | 23 | $264 | $11 |
2020: 17 drugs
| Cosentyx Pen (2 Pens) | 12 | $64,455 | $5,371 |
| Calcipotriene | 12 | $4,362 | $363 |
| Betamethasone Diprop Augmented | 54 | $3,138 | $58 |
| Clindamycin Phosphate | 35 | $2,442 | $70 |
| Econazole Nitrate | 12 | $2,381 | $198 |
| Fluorouracil | 12 | $1,622 | $135 |
| Fluocinonide | 26 | $1,595 | $61 |
| Tretinoin | 14 | $1,426 | $102 |
| Clobetasol Propionate | 20 | $1,357 | $68 |
| Metronidazole | 14 | $931 | $66 |
| Triamcinolone Acetonide | 53 | $678 | $13 |
| Spironolactone | 29 | $677 | $23 |
| Ketoconazole | 30 | $522 | $17 |
| Ciclopirox | 15 | $477 | $32 |
| Doxycycline Monohydrate | 23 | $368 | $16 |
| Mupirocin | 20 | $278 | $14 |
| Finasteride | 21 | $119 | $6 |
2019: 24 drugs
| Cosentyx Pen (2 Pens) | 13 | $65,041 | $5,003 |
| Betamethasone Diprop Augmented | 95 | $6,395 | $67 |
| Clindamycin Phosphate | 46 | $4,546 | $99 |
| Tretinoin | 32 | $3,687 | $115 |
| Clobetasol Propionate | 19 | $3,016 | $159 |
| Fluorouracil | 22 | $2,872 | $131 |
| Metronidazole | 25 | $1,809 | $72 |
| Fluocinonide | 29 | $1,781 | $61 |
| Doxycycline Hyclate | 17 | $1,406 | $83 |
| Imiquimod | 14 | $1,197 | $86 |
| Desonide | 11 | $970 | $88 |
| Methotrexate | 16 | $860 | $54 |
| Doxycycline Monohydrate | 34 | $773 | $23 |
| Triamcinolone Acetonide | 72 | $725 | $10 |
| Ciclopirox | 11 | $643 | $58 |
| Ketoconazole | 33 | $595 | $18 |
| Ciclopirox | 22 | $576 | $26 |
| Spironolactone | 16 | $472 | $29 |
| Acyclovir | 11 | $346 | $31 |
| Mupirocin | 20 | $341 | $17 |
| Terbinafine | 22 | $157 | $7 |
| Finasteride | 15 | $139 | $9 |
| Prednisone | 14 | $97 | $7 |
| Hydrocortisone | 12 | $90 | $8 |
2018: 15 drugs
| Betamethasone Diprop Augmented | 103 | $5,916 | $57 |
| Finacea | 12 | $4,589 | $382 |
| Tretinoin | 30 | $3,999 | $133 |
| Clobetasol Propionate | 21 | $3,864 | $184 |
| Clindamycin Phosphate | 35 | $3,302 | $94 |
| Fluocinonide | 24 | $2,458 | $102 |
| Methotrexate | 23 | $1,057 | $46 |
| Ciclopirox | 12 | $1,012 | $84 |
| Metronidazole | 11 | $853 | $78 |
| Triamcinolone Acetonide | 65 | $750 | $12 |
| Spironolactone | 24 | $693 | $29 |
| Ketoconazole | 19 | $278 | $15 |
| Mupirocin | 18 | $266 | $15 |
| Doxycycline Monohydrate | 11 | $99 | $9 |
| Finasteride | 15 | $71 | $5 |
2017: 16 drugs
| Finacea | 18 | $9,198 | $511 |
| Clobetasol Propionate | 31 | $6,114 | $197 |
| Tretinoin | 22 | $3,742 | $170 |
| Fluocinonide | 30 | $3,262 | $109 |
| Clindamycin Phosphate | 20 | $2,316 | $116 |
| Metronidazole | 16 | $1,698 | $106 |
| Desonide | 14 | $1,681 | $120 |
| Betamethasone Dipropionate | 30 | $1,342 | $45 |
| Acyclovir | 16 | $1,176 | $74 |
| Spironolactone | 37 | $905 | $24 |
| Methotrexate | 14 | $874 | $62 |
| Ketoconazole | 24 | $592 | $25 |
| Doxycycline Monohydrate | 25 | $568 | $23 |
| Triamcinolone Acetonide | 55 | $533 | $10 |
| Mupirocin | 22 | $306 | $14 |
| Cephalexin | 11 | $129 | $12 |
2016: 14 drugs
| Clobetasol Propionate | 68 | $15,780 | $232 |
| Fluocinonide | 51 | $7,433 | $146 |
| Desonide | 18 | $2,880 | $160 |
| Fluorouracil | 17 | $2,654 | $156 |
| Econazole Nitrate | 11 | $2,449 | $223 |
| Metronidazole | 15 | $1,950 | $130 |
| Tretinoin | 16 | $1,373 | $86 |
| Ketoconazole | 32 | $945 | $30 |
| Acyclovir | 19 | $910 | $48 |
| Doxycycline Monohydrate | 23 | $577 | $25 |
| Spironolactone | 24 | $553 | $23 |
| Triamcinolone Acetonide | 42 | $543 | $13 |
| Minocycline | 11 | $411 | $37 |
| Mupirocin | 18 | $205 | $11 |
2015: 12 drugs
| Clobetasol Propionate | 35 | $8,576 | $245 |
| Econazole Nitrate | 29 | $8,345 | $288 |
| Fluocinonide | 25 | $3,762 | $150 |
| Desonide | 13 | $2,348 | $181 |
| Tretinoin | 12 | $1,837 | $153 |
| Clindamycin Phosphate | 16 | $1,769 | $111 |
| Triamcinolone Acetonide | 41 | $1,038 | $25 |
| Spironolactone | 24 | $698 | $29 |
| Doxycycline Monohydrate | 13 | $443 | $34 |
| Ketoconazole | 19 | $301 | $16 |
| Mupirocin | 12 | $184 | $15 |
| Acyclovir | 12 | $118 | $10 |
2014: 8 drugs
| Clobetasol Propionate | 30 | $4,640 | $155 |
| Imiquimod | 15 | $3,841 | $256 |
| Desonide | 14 | $3,760 | $269 |
| Fluocinonide | 31 | $2,305 | $74 |
| Spironolactone | 18 | $744 | $41 |
| Triamcinolone Acetonide | 36 | $545 | $15 |
| Ketoconazole | 19 | $379 | $20 |
| Mupirocin | 19 | $193 | $10 |
2013: 7 drugs
| Calcipotriene | 11 | $8,452 | $768 |
| Desonide | 17 | $2,421 | $142 |
| Doxycycline Hyclate | 18 | $1,861 | $103 |
| Clobetasol Propionate | 27 | $1,507 | $56 |
| Fluocinonide | 25 | $1,046 | $42 |
| Triamcinolone Acetonide | 38 | $604 | $16 |
| Mupirocin | 18 | $256 | $14 |
Money from drug and device companies
$278 in 2025
| 2025 | 4 | 19 | None | $278 |
| 2024 | 5 | 23 | None | $406 |
| 2023 | 8 | 43 | None | $754 |
| 2022 | 7 | 18 | None | $380 |
| 2021 | 5 | 7 | None | $189 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Cibinqo | $176 | 13 payments
|
| Organon | None | $72 | 4 payments
|
| Genzyme | Dupixent | $15 | 1 payment
|
| Arcutis Biotherapeutics | Zoryve | $15 | 1 payment
|
See all 19 published payments
| Organon | Meals · 2025-12-11 | None | $7 |
| Pfizer | Meals · 2025-12-02 | Cibinqo | $11 |
| Organon | Meals · 2025-11-04 | None | $29 |
| Pfizer | Meals · 2025-10-28 | Cibinqo | $14 |
| Pfizer | Meals · 2025-10-21 | Cibinqo | $15 |
| Organon | Meals · 2025-09-23 | None | $18 |
| Pfizer | Meals · 2025-09-16 | Cibinqo | $12 |
| Pfizer | Meals · 2025-08-05 | Cibinqo | $13 |
| Genzyme | Meals · 2025-07-15 | Dupixent | $15 |
| Organon | Meals · 2025-07-08 | None | $18 |
| Pfizer | Meals · 2025-07-01 | Cibinqo | $15 |
| Arcutis Biotherapeutics | Meals · 2025-04-28 | Zoryve | $15 |
| Pfizer | Meals · 2025-04-22 | Cibinqo | $17 |
| Pfizer | Meals · 2025-04-15 | Cibinqo | $12 |
| Pfizer | Meals · 2025-03-20 | Cibinqo | $9 |
| Pfizer | Meals · 2025-03-18 | Cibinqo | $19 |
| Pfizer | Meals · 2025-02-27 | Litfulo | $8 |
| Pfizer | Meals · 2025-02-11 | Cibinqo | $16 |
| Pfizer | Meals · 2025-01-07 | Cibinqo | $16 |
See earlier years (2024, 2023, 2022, 2021)
2024: $406
| Dermavant Sciences | Vtama | $171 | 10 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $108 | 6 payments
|
| Pfizer | Cibinqo | $51 | 3 payments
|
| Celgene | Sprycel | $44 | 2 payments
|
| Arcutis Biotherapeutics | Zoryve | $34 | 2 payments
|
2023: $754
| E.R. Squibb & Sons L.L.C. | Sotyktu | $237 | 15 payments
|
| Abbvie | Skyrizi | $178 | 10 payments
|
| Dermavant Sciences | Vtama | $158 | 10 payments
|
| Sun Pharmaceutical Industries | Winlevi | $61 | 2 payments
|
| LEO Pharma | Adbry | $38 | 2 payments
|
| Arcutis Biotherapeutics | None | $34 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $34 | 1 payment
|
| Lilly USA | Taltz | $14 | 1 payment
|
2022: $380
| Abbvie | Skyrizi | $121 | 7 payments
|
| Janssen Biotech | Tremfya | $81 | 3 payments
|
| Novartis Pharmaceuticals | Cosentyx | $49 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $39 | 2 payments
|
| Pfizer | Eucrisa | $37 | 2 payments
|
| Amgen | Otezla | $30 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $22 | 1 payment
|
2021: $189
| Janssen Biotech | Tremfya | $86 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $40 | 1 payment
|
| VYNE Pharmaceuticals | Amzeeq | $27 | 1 payment
|
| Sun Pharmaceutical Industries | Blu-U | $18 | 1 payment
|
| AbbVie | Skyrizi | $17 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 96.4 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1659314961
- Licence
- MA 1952, NH 1697
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant, medical (363AM0700X)
- Mailing address
- 784 Central Ave, Dover, NH, 03820
- NPI first listed
- 2006-06-14
- NPI last updated
- 2021-04-28
- NPI record certified
- 2021-04-28
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 784 Central Ave, Dover, NH, 03820
This office lists an electronic records connection.